Latest filing published 09 Jan 2026 for Anaptysbio, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Dennis Mulroy on record concern Anaptysbio, Inc, in the capacity of finance chief. Over a trading history stretching from 15 November 2021 to 7 January 2026, the count stands at 21 filings.
The open-market record consists of 7 sales worth €1.1M, with no purchase. Outside the open market, there are 3 share grants and 11 option exercises. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 9 January 2026: an option exercise, in Anaptysbio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations